Invion Limited
ASX:IVX.AX
0 (AUD) • At close September 16, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Invion Limited |
Symbool | IVX.AX |
Munteenheid | AUD |
Prijs | 0.002 |
Beurswaarde | 13,533,180 |
Dividendpercentage | 0% |
52-weken bereik | 0.002 - 0.008 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Thian Chew |
Website | https://www.inviongroup.com |
An error occurred while fetching data.
Over Invion Limited
Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (AUD)
Cijfers zijn in miljoenen (AUD)